| Net Cash Provided by (Used in) Operating Activities |
$7,300 |
USD |
58% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$7,300 |
USD |
-58% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
9,948,330 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$0 |
USD |
|
Q1 2024 |
Q1 2023 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$38,548 |
USD |
35% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$38,548 |
USD |
35% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$183,562 |
USD |
35% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$41,879 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Interest Expense |
$393 |
USD |
0% |
Q3 2024 |
Q3 2024 |